What is it?

Angelman syndrome is a complex genetic disorder that primarily affects the nervous system.1

What causes it?

Typically, people inherit a working copy of the UBE3A gene from each parent (so they have two copies). In certain parts of the brain, only the copy inherited from a person’s mother (the maternal copy) is active. Angelman syndrome occurs when there is a mutation (change) or deletion in a person’s maternal UBE3A gene, so they have no working copies of the gene in those areas of the brain.1

What are some of the common symptoms?1

  • Developmental delay
  • Behavioral problems
  • Intellectual disability
  • Severe speech impairment
  • Movement and balance problems (ataxia)
  • Recurrent seizures (epilepsy)
  • Small head size (microcephaly)

How many people have it?

Angelman syndrome affects an estimated 1 in 12,000 to 20,000 people globally.1

Common names for Angelman Syndrome

  • AS1

1Angelman Syndrome. Nation Institutes of Health: Genetics Home Reference Website. https://ghr.nlm.nih.gov/condition/angelman-syndrome#. Published October 29, 2019. Accessed December 5, 2019.

*These organizations are an incomplete listing of rare disease support organizations and are not controlled by, endorsed by, or affiliated with Ultragenyx Pharmaceutical Inc. The list is meant for informational purposes only and is not intended to replace your healthcare professional’s medical advice. Ask your doctor or nurse any questions you may have about your disease or treatment plan. If you would like to have your group added to the list, please contact patientadvocacy@ultragenyx.com.